News

News
Partner news

Ultromics Announces Collaboration with Janssen to Develop AI for Patients with Amyloidosis with Cardiac Involvement

Read full story
Partner news

F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics

Read full story
JNJ Press releases

Johnson & Johnson Innovation becomes a leading partner of Sitem Startup Club

Read full story
In the media

Janssen on driving R&D innovation with data science

Read full story
In the media

Mestag Therapeutics

Read full story
JNJ Press releases

LAVA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS SECOND QUARTER RESULTS

Read full story
JNJ Press releases

New report reveals strength of the UK’s thriving genomics sector

Read full story
JNJ Press releases

MESTAG THERAPEUTICS EXTENDS SEED FINANCING TO $45 MILLION AND WELCOMES NEW INVESTORS FORBION, GV (FORMERLY GOOGLE VENTURES) AND NORTHPOND VENTURES

Read full story
Partner news

Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development

Read full story
Partner news

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Read full story
Partner news

Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen

Read full story
Partner news

£10 million research collaboration to detect lung cancer earlier

Read full story